Public Health - Ibogaine Clinical Research Grant Program - Establishment (Veterans Mental Health Innovations Act)

SB 527 establishes Maryland's Ibogaine Clinical Research Grant Program to fund clinical trials on ibogaine for treating opioid use disorder and other neurological conditions. The program provides up to three annual grants to eligible Maryland-based research institutions with neuroscience expertise, requiring matching funds equal to the grant amount. Funding comes from the Opioid Restitution Fund ($500,000 annually for fiscal years 2028-2030), administered by the Department of Health in consultation with the Department of Veterans and Military Families. Institutions must conduct FDA-reviewed trials, submit quarterly progress and financial reports, and report annually to the General Assembly on grant usage and trial outcomes. The bill directly affects research institutions, veterans (via the veterans mental health focus), and the Opioid Restitution Fund.